In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Biofrontera Inc (NASDAQ: BFRI) was $0.57 for the day, down -20.83% from the previous closing price of $0.72. In other words, the price has decreased by -$20.83 from its previous closing price. On the day, 0.33 million shares were traded. BFRI stock price reached its highest trading level at $0.78 during the session, while it also had its lowest trading level at $0.5547.
Ratios:
Our analysis of BFRI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.80 and its Current Ratio is at 1.15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BFRI now has a Market Capitalization of 6639544 and an Enterprise Value of 8117544. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.18. Its current Enterprise Value per Revenue stands at 0.218 whereas that against EBITDA is -0.464.
Stock Price History:
The Beta on a monthly basis for BFRI is 0.58, which has changed by -0.33944952 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, BFRI has reached a high of $1.87, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is -34.87%, while the 200-Day Moving Average is calculated to be -32.18%.
Shares Statistics:
BFRI traded an average of 126.26K shares per day over the past three months and 75870 shares per day over the past ten days. A total of 11.65M shares are outstanding, with a floating share count of 9.95M. Insiders hold about 14.60% of the company’s shares, while institutions hold 21.71% stake in the company. Shares short for BFRI as of 1765756800 were 50833 with a Short Ratio of 0.40, compared to 1763078400 on 32743. Therefore, it implies a Short% of Shares Outstanding of 50833 and a Short% of Float of 0.44999999999999996.
Earnings Estimates
. The current rating of Biofrontera Inc (BFRI) reflects the combined expertise of 1.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.18 and low estimates of -$0.18. Analysts are recommending an EPS of between -$1.51 and -$1.51 for the fiscal current year, implying an average EPS of -$1.51. EPS for the following year is -$0.23, with 1.0 analysts recommending between -$0.23 and -$0.23.
Revenue Estimates
It is expected that $90B in revenue will be generated in . The current quarter, according to 2 analysts. It ranges from a high estimate of $16.07M to a low estimate of $15M. As of . The current estimate, Biofrontera Inc’s year-ago sales were $12.56MFor the next quarter, 2 analysts are estimating revenue of $9.1M. There is a high estimate of $9.1M for the next quarter, whereas the lowest estimate is $9.1M.
A total of 2 analysts have provided revenue estimates for BFRI’s current fiscal year. The highest revenue estimate was $40.68M, while the lowest revenue estimate was $39.6M, resulting in an average revenue estimate of $40.14M. In the same quarter a year ago, actual revenue was $37.32MBased on 2 analysts’ estimates, the company’s revenue will be $44.54M in the next fiscal year. The high estimate is $44.98M and the low estimate is $44.1M.
